Compare ALLO & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | PD |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | 152 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.4M | 636.9M |
| IPO Year | 2018 | 2019 |
| Metric | ALLO | PD |
|---|---|---|
| Price | $2.02 | $6.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 9 |
| Target Price | $8.35 | ★ $12.63 |
| AVG Volume (30 Days) | ★ 8.0M | 1.9M |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.09 | ★ 416.95 |
| EPS | N/A | ★ 1.87 |
| Revenue | N/A | ★ $492,546,000.00 |
| Revenue This Year | N/A | $3.58 |
| Revenue Next Year | $142,416.42 | $2.88 |
| P/E Ratio | ★ N/A | $3.57 |
| Revenue Growth | N/A | ★ 5.36 |
| 52 Week Low | $0.99 | $5.70 |
| 52 Week High | $4.46 | $17.45 |
| Indicator | ALLO | PD |
|---|---|---|
| Relative Strength Index (RSI) | 38.70 | 48.83 |
| Support Level | $1.85 | $6.01 |
| Resistance Level | $2.71 | $7.91 |
| Average True Range (ATR) | 0.14 | 0.38 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 8.33 | 27.08 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.